Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Growth
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Growth

Add To Compare

34.071 (0.398%)
NAV on June 04, 2025
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,223 cr
Turnover Ratio 28.44%
Expense Ratio 0.67%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: 0.59%
  • 1Y: 21.01%
  • 3M: 10.00%
  • 3Y: 25.30%
  • 6M: -3.90%
  • 5Y: 22.78%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Meeta Shetty (Since about 4 years) Rajat Srivastava (Since 9 months)
ISIN INF277K019A3
Fund Family Tata
P/E Ratio 37.76
P/B Ratio 5.68
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 4.08
Beta 0.95
R-Squared 96.52
Info Ratio 1.33
Tracking Err 3.14
Sortino 1.902
Sharpe 1.043
Std Dev 16.182
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 2.46%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 97.54%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Sbi
SBI Healthcare Opportunities Fund Direct Growth
478.047 23.86% 3,671 cr 0.9% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund